[The frequency of developmental abnormalities according to autopsy findings in Kecskemet and Debrecen regional hospitals].

L. Józsa,G. Győri,G. Lusztig

1961-12-01

Abstract:

What problem does this paper attempt to address?

Treatment Experience of Severe Abdominal Infection after Orthotopic Liver Transplantation

Y-G Wang,J-S Wu,B. Jiang,J-H Wang,C-P Liu,C. Peng,B-Z Tian

DOI: https://doi.org/10.7727/wimj.2014.055

2015-01-01

West Indian Medical Journal

Abstract:This study aims to investigate the causes and treatment experience of severe abdominal infection after orthotopic liver transplantation. Clinical data were retrospectively analysed in perioperative severe abdominal infection of 186 orthotopic liver transplantation cases from March 2004 to November 2011. Among the 186 patients, 16 cases had severe abdominal infection: five cases had bile duct anastomotic leakage-inducing massive hydrops and infection under liver interstice, 10 cases had extensive bleeding of surgical wound leading to massive haematocele and infection around the liver, and one case had postoperative lower oesophageal fistula leakage causing massive hydrops and infection under the left diaphragm. After definite diagnosis, 12 cases underwent surgery within three days, with no death. Among the four cases that underwent surgery three days after diagnosis, one case died of multiple-organ failure five days after abdominal cavity exploration, which was performed 21 days after liver transplantation. Severe abdominal infections after liver transplantation were the most common causes of death in perioperative liver transplantation. Comprehensive treatment with efficacious antibiotics, multiple-organ support, controlled surgical removal of the lesion, and adequate drainage establishment was the key to the entire treatment.
Cardiovascular and renal complications in patients receiving a solid-organ transplant

Geraldine Diaz,Michael O'Connor

DOI: https://doi.org/10.1097/MCC.0b013e328348bf1f

Abstract:Purpose of review: Cardiovascular and renal complications among solid-organ transplant recipients are a frequent source of morbidity. Appropriate management of these complications throughout the perioperative period significantly affects long-term recipient survival. This review details the identification, management, and potential preventive strategies for perioperative cardiovascular and renal complications among solid-organ transplant recipients. Recent findings: Abdominal transplant candidates have a significantly higher prevalence of risk factors for obstructive coronary artery disease than the general population. There is no consensus on pretransplant screening for coronary artery disease or determination of perioperative risk in candidates awaiting transplantation. Limitations of noninvasive cardiac screening tests such as dobutamine stress echocardiography and myocardial perfusion scintigraphy complicate preoperative evaluation and cardiac risk stratification. Coronary angiography remains the definitive mechanism for determining the presence and severity of coronary artery disease prior to transplantation; however, the relationship between angiographically documented coronary artery disease and cardiovascular morbidity after transplantation is inconsistent. This has raised speculation that perioperative adverse cardiac events are not principally caused by obstructive coronary artery disease but other acute events related to surgical intervention and allograft function. Current data indicate coronary angiography is safe even with patients demonstrating renal insufficiency. A cardiac screening program should reflect the patient population, dynamics of the transplant program, and institutional expertise. The development of classification schemes for defining and categorizing acute kidney injury reflects the importance of preserved renal function in long-term recipient survival. The potential of serum markers as indicators of acute kidney injury has provided a foundation for understanding the global influence of surgical intervention and allograft function upon recipient survival. Summary: Meticulous attention to all aspects of the transplant process, including operative events and early allograft function, is necessary to minimize morbidity. Further research is necessary to identify mechanisms that support and improve early allograft function to optimize recipient long-term survival.
Care for the organ transplant recipient on the intensive care unit

M W F van den Hoogen,L Seghers,O C Manintveld,S Roest,J A Bekkers,C M den Hoed,R C Minnee,H R H de Geus,R J van Thiel,D A Hesselink

DOI: https://doi.org/10.1016/j.jcrc.2021.03.003

Abstract:All transplant recipients receive tacrolimus, mycophenolate and glucocorticoids and these drugs have many side-effects and drug-drug interactions. Common complications include surgical complications, infections, rejection and acute kidney injury. Infections as CMV and PJP can be prevented with prophylactic treatment. Given the complexity of organ transplant recipients a multi-disciplinary team of intensivists, surgeons, pharmacists and transplant specialists is essential. After heart transplantation a temporary pacemaker is required until the conduction system recovers. Stiffening of the heart and increased cardiac markers indicate rejection. An endomyocardial biopsy is performed via the right jugular vein, necessitating its preservation. For lung transplant patients, early intervention for aspiration is warranted to prevent chronic rejection. Risk of any infection is high, requiring active surveillance and intensive treatment, mainly of fungal infections. The liver is immunotolerant requiring lower immunosuppression. Transplantation surgery is often accompanied by massive blood loss and coagulopathy. Other complications include portal vein or hepatic artery thrombosis and biliary leakage or stenosis. Kidney transplant recipients have a high risk of cardiovascular disease and posttransplant anemia should be treated liberally. After postmortal transplantation, delayed graft function is common and dialysis is continued. Ureteral anastomosis complications can be diagnosed with ultrasound.
Expert Consensus on Perioperative Management of Liver Transplantation in Adults with Acute-on-chronic Liver Failure

Guihua Chen,Yang,Huimin Yi,Jianrong Liu,Pinglan Lu,Lijuan Li,Mingming Fan,Xiaomeng Yi,Haijin Lv,Xuxia Wei,Yuling An,Xueli Bai,Jinglin Cao,Bicheng Chen,Hao Chen,Ming Chen,Wei Chen,Xiaoping Chen,Zhonglin Cui,Feiwen Deng,Guosheng Du,Juanming Du,Lang Feng,Binsheng Fu,Dazhi Fu,Xinpu Gao,Jun He,Qiang He,Xin He,Ziqing Hei,Xiquan Hu,Zemin Hu,Lei Huang,Xiaowu Huang,Ruipeng Jia,Wentao Jiang,Jianhui Li,Jianjun Li,Jian Li,Hua Li,Tao Li,Xianliang Li,Xiao Li,Yang Li,Guangming Li,Fang Liu,Yong Liu,Yu Liu,Gangjian Luo,Hui Luo,Guoyue Lv,Ling Lv,Wei Meng,Yanwen Peng,Haizhi Qi,Yongbing Qian,Yan Qin,Jianghua Ran,Fangfei Ren,Jie Ren,Conghuan Shen,Wei Shi,Yinghong Shi,Xiaomin Shi,Liying Sun,Qiquan Sun,Qipeng Sun,Xiaodong Sun,Kaishan Tao,Tuerganaili Aji,Chidan Wan,Genshu Wang,Guoying Wang,Shaoping Wang,Jiandong Wang,Lin Wang,Shengjun Wang,Yuantao Wang,Zhengxin Wang,Zhihui Wang,Zhang Wen,Zhongjun Wu,Qiang Xia,Qinfen Xie,Jun Xiong,Yan Xiong,Chi Xu,Leibo Xu,Haiyan Yang,Jiaying Yang,Jun Yang,Qing Yang,Zhaoxu Yang,Jia Yao,Junsheng Ye,Huanfa Yi,Shuhong Yi,Ming Yuan,Xun Zeng,Feng Zhang,Jian Zhang,Leida Zhang,Ming Zhang,Tong Zhang,Xufeng Zhang,Yingcai Zhang,Xianling Zhang,Hui Zhao,Lei Zhao,Hongchuan Zhao,Yong Zhao,Haiqing Zheng,Lin Zhong,Guangwen Zhou,Lin Zhou,Peijun Zhou,Xiaodan Zhu,Zhijun Zhu,Li Zhuang,Jinfeng Zhuo,Yizhou Zou

DOI: https://doi.org/10.1016/j.livres.2021.03.002

2021-01-01

Liver Research

Abstract:Acute-on-chronic liver failure (ACLF) is a syndrome in which acute liver failure with extrahepatic organ failure occurs on chronic liver disease. Recently, liver transplantation is the only effective treatment for ACLF. There is still room for discussion on the optimal surgery timing for ACLF, perioperative infection prevention and control, and maintenance of nutrition and organ function. The Transplantation Immunology Committee of Branch of Organ Transplantation Physician of Chinese Medical Doctor Association and Enhanced Recovery of Liver Transplantation Group of Enhanced Recovery after Surgery Committee of Chinese Research Hospital Association invited relevant experts to discuss the perioperative management of ACLF liver transplantation in areas including surgery timing, organ protection, nutritional support, infection prevention and control, rehabilitation exercises, regulation of the internal environment, etc. An expert consensus was developed as reference for clinicians. (c) 2021 The Third Affiliated Hospital of Sun Yat-sen University. Publishing Services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Perioperative Management for Patients with a Solid Organ Transplant

Laura Petrò,Alessandra Ponti,Elena Roselli,Manlio Prosperi,Andrea De Gasperi

DOI: https://doi.org/10.1007/978-3-319-94189-9_6

2019-01-01

Abstract:The need for surgery in the early or late posttransplant period is increasing in the solid organ transplanted population: between 15% and 40% of the solid organ transplant recipients will undergo invasive procedures:—as a consequence, these patients have to be assessed for every form of anesthesia (general, locoregional) or sedation (from moderate to deep sedation) to undergo elective and emergency non-transplant surgery, for interventional radiologic and endoscopic procedures (gastrointestinal, thoracic, or urologic) and for traumatic events. Aging of the recipients, the increasing number of comorbidities (particularly cardiopulmonary, metabolic, and gastrointestinal), and the occurrence of de novo cancer are creating a new, relevant form of chronic illness population every anesthesiologist can find in everyday clinical practice. We will review the anesthesiological and perioperative management of heart-, lung-, kidney-, and liver-transplanted patients, focusing on the peculiar aspects of the new posttransplant physiology introduced by the denervated graft, able to impact on the conduction of the surgical anesthesia and on the immediate postoperative period. Preoperative assessment and organ-specific anesthesiological issues will be reviewed.
Surgical Procedures in Five Heart Transplant Patients

LI Jun,WANG Chun-sheng,CHEN Hao,LAI Hao,YANG Shou-guo,ZHU Shi-jie

2008-01-01

Abstract:ObjectiveTo summarize the surgical outcomes and clinical experience of surgical disease for patients having undergone orthotopic heart transplantation.MethodsFive cardiac transplant recipients requiring surgical management due to other surgical diseases including acute cholecystitis in 2 patients,acute appendicitis,bilateral mammary hypertrophy and lung tumor in 1 patients,respectively.The mean age of the entire group at the time of reoperation was 44.6 years(14-60 years) and the average time of operative procedures after transplant was 16.4 months(4-37 months).Four patients were treated with triple immunosuppression,including cyclosporine A(CsA) or tacrolimus,mycophenolate mofetil and corticosteroids,respectively.One patient received double-therapy of CsA and mycophenolate mofetil with early withdrawal of corticosteroids.All the acute cholecystitis and appendicitis patients underwent open cholecystectomy and appendectomy emergently.Reduction mammaplasty was performed on the bilateral mammary hypertrophy patients.For the lung tumor patient,right upper lobectomy and nodes excision were undertaken radically after the sample proved to be malignancy by the thoracoscopy.Closely surveillance at concentration of CsA or FK506 was performed continueously in order to adjust the effective blood concentration in a steady way by which acute rejection can be avoided.The pathways which pathogen organisms invading the human body were controlled strictly as well as intension on anti-infection treatment during perioperative period.ResultsFour patients discharged to home within 2 weeks.Only one patient needed further treatment in Digestive Department after emergent cholecystectomy due to gastric retention.And she was discharged after 66 days.No acute rejections or operative complications such as severe infection or bleeding were found during the perioperative period.The average length of stay was 21.3 days(8-66 days).During the follow-up from 1 month to 13 months,there was no relapse or allograft disfunction performed on any patients.All of them enjoy quality lives.ConclusionsMore attention should be paid to regular follow-up after transplantation,by which the emergent surgical diseases can be diagnosed and treated earlier and more effectively.Cardiac transplant recipients who subsequently require surgical intervention do quite well overall.Most of them can obtain excellent surgical outcomes.
Infection in Organ Transplantation

J. A. Fishman

DOI: https://doi.org/10.1111/ajt.14208

IF: 9.369

2017-03-10

American Journal of Transplantation

Abstract:The prevention, diagnosis, and management of infectious disease in transplantation are major contributors to improved outcomes in organ transplantation. The risk of serious infections in organ recipients is determined by interactions between the patient's epidemiological exposures and net state of immune suppression. In organ recipients, there is a significant incidence of drug toxicity and a propensity for drug interactions with immunosuppressive agents used to maintain graft function. Thus, every effort must be made to establish specific microbiologic diagnoses to optimize therapy. A timeline can be created to develop a differential diagnosis of infection in transplantation based on common patterns of infectious exposures, immunosuppressive management, and antimicrobial prophylaxis. Application of quantitative molecular microbial assays and advanced antimicrobial therapies have advanced care. Pathogen-specific immunity, genetic polymorphisms in immune responses, and dynamic interactions between the microbiome and the risk of infection are beginning to be explored. The role of infection in the stimulation of alloimmune responses awaits further definition. Major hurdles include the shifting worldwide epidemiology of infections, increasing antimicrobial resistance, suboptimal assays for the microbiologic screening of organ donors, and virus-associated malignancies. Transplant infectious disease remains a key to the clinical and scientific investigation of organ transplantation.
Management of kidney transplant recipients for primary care practitioners

Manal Alotaibi,Brandon Trollinger,Sam Kant

DOI: https://doi.org/10.1186/s12882-024-03504-2

2024-03-19

BMC Nephrology

Abstract:Patients with kidney transplants have a significant co-morbidity index, due to a high number of pre-existing conditions and use of immunosuppression medications. These patients are at higher risk of developing conditions such as hypertension, dyslipidemia, post-transplant diabetes, cardiovascular events, and anemia. Moreover, they are particularly susceptible to infections such as urinary tract infections or pyelonephritis, cancers, and gastrointestinal complications such as diarrhea, which in turn may be attributed to medication adverse effects or infectious causes. Along with these concerns, meticulous management of electrolytes and allograft function is essential. Prior to prescribing any new medications, it is imperative to exercise caution in identifying potential interactions with immunosuppression drugs. This review aims to equip primary care practitioners to address these complex issues and appropriate methods of delivering care to this rapidly growing highly susceptible group.

urology & nephrology
Transplantation: current developments and future directions

Roy Y Calne

DOI: https://doi.org/10.2741/2347

2007-05-01

Abstract:Organ transplantation has emerged from a few sporadic failed attempts to one of the most successful branches of surgery in the course of 50 years since the first identical twin transplant was performed in Boston. In this article I will attempt to portray the historical background and the recent shift of attitude regarding immunosuppression for solid organ transplants. Previously a culture of increasing immunosuppression and incorporating new and powerful agents into an already effective regimen has resulted in over-immunosuppression and more sepsis without an improvement in long-term graft survival. Over-immunosuppression is probably detrimental in preventing the natural control and "switching off" of the immune response as a vital function of the immune system and as a consequence any attempts to produce immunological tolerance are likely to be impaired by excessive immunosuppressive regimens. I will therefore,, explain and advocate a minimalistic approach to immunosuppression, a background on tissue typing and a summary of clinical results. Now that the procedure is perceived worldwide as an excellent therapy for previously doomed patients, there is an increasing mismatch between the number of donor organs available and patients in need of a graft. This has produced ethical dilemmas previously unknown in the medical profession. These are extremely important considerations as they can undermine the Hippocratic tradition and the high ethical standing previously enjoyed by our profession.
Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients.

Samuel Chan,Samantha Ng,Hooi P Chan,Elaine M Pascoe,Elliott Geoffrey Playford,Germaine Wong,Jeremy R Chapman,Wai H Lim,Ross S Francis,Nicole M Isbel,Scott B Campbell,Carmel M Hawley,David W Johnson

DOI: https://doi.org/10.1002/14651858.CD013209.pub2

IF: 8.4

2020-08-19

Cochrane Database of Systematic Reviews

Abstract:Solid organ transplant recipients are at high risk for infections due to the complexity of surgical procedures combined with the impact of immunosuppression. No consensus exists on the role of antibiotics for surgical site infections in solid organ transplant recipients. To assess the benefits and harms of prophylactic antimicrobial agents for preventing surgical site infections in solid organ transplant recipients. The Cochrane Kidney and Transplant Register of Studies was searched up to 21 April 2020 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal, and ClinicalTrials.gov. All randomised controlled trials (RCTs) and quasi‐RCTs in any language assessing prophylactic antibiotics in preventing surgical site infections in solid organ transplant recipients at any time point after transplantation. Two authors independently determined study eligibility, assessed quality, and extracted data. Primary outcomes were surgical site infections and antimicrobial resistance. Other outcomes included urinary tract infections, pneumonias and septicaemia, death (any cause), graft loss, graft rejection, graft function, adverse reactions to antimicrobial agents, and outcomes identified by the Standardised Outcomes of Nephrology Group (SONG), specifically graft health, cardiovascular disease, cancer and life participation. Summary effect estimates were obtained using a random‐effects model and results were expressed as risk ratios (RR) and 95% confidence intervals (CI). The quality of the evidence was assessed using the risk of bias and the GRADE approach. We identified eight eligible studies (718 randomised participants). Overall, five studies (248 randomised participants) compared antibiotics versus no antibiotics, and three studies (470 randomised participants) compared extended duration versus short duration antibiotics. Risk of bias was assessed as high for performance bias (eight studies), detection bias (eight studies) and attrition bias (two studies). It is uncertain whether antibiotics reduce the incidence of surgical site infections as the certainty of the evidence has been assessed as very low (RR 0.42, 95% CI 0.21 to 0.85; 5 studies, 226 participants; I 2 = 25%). The certainty of the evidence was very low for all other reported outcomes (death, graft loss, and other infections). It is uncertain whether extended duration antibiotics reduces the incidence of surgical site infections in either solid organ transplant recipients (RR 1.19, 95% CI 0.58 to 2.48; 2 studies, 302 participants; I 2 = 0%) or kidney‐only transplant recipients (RR 0.50, 95% CI 0.05 to 5.48; 1 study, 205 participants) as the certainty of the evidence has been assessed as very low. The certainty of the evidence was very low for all other reported outcomes (death, graft loss, and other infections). None of the eight included studies evaluated antimicrobial agent adverse reactions, graft health, cardiovascular disease, cancer, life participation, biochemical and haematological parameters, intervention cost, hospitalisation length, or overall hospitalisation costs. Due to methodological limitations, risk of bias and significant heterogeneity, the current evidence for the use of prophylactic perioperative antibiotics in transplantation is of very low quality. Further high quality, adequately powered RCTs would help better inform clinical practice. What is the issue? People receiving organ transplants are at high risk of infections due to the complex surgery and the weakening of the body's immune defence against infection by anti‐rejection drugs. The germs causing infection around the time of transplantation may come from the person's body, the transplanted organ, or the environment. Depending on the type of organ transplanted and the era in which the transplant took place, surgical site infections have been reported to occur following 3% to 53% of transplant operations. A surgical site infection is an infection that occurs after surgery in the part of the body where the surgery took place. This could include redness of the wound and/or a discharge of pus, which, if not treated with antibiotics or further surgery, could lead to bloodstream infection, infection of other organs in the body (including the transplant organ) or even death. Avoiding surgical site infection may improve patient and transplant survival. Giving antibiotics around the time of the transplant surgery may help to prevent surgical site infections but has not been studied in a systematic way. Giving antibiotics is also not without risk of harm since antibiotics are known to encourage the develop of antibiotic‐resistant germs, cause side effects like diarrhoea, and cost money. Wh -Abstract Truncated-

medicine, general & internal
Open Abdominal Management for Damage Control in Liver Transplantation: A Single-center Experience

Takanobu Hara,Akihiko Soyama,Hajime Matsushima,Hajime Imamura,Mampei Yamashita,Hironori Ishizaki,Rintaro Yano,Sojiro Matsumoto,Taiga Ichinomiya,Ushio Higashijima,Motohiro Sekino,Masayuki Fukumoto,Kazushige Migita,Yuta Kawaguchi,Tomohiko Adachi,Tetsuya Hara,Susumu Eguchi

DOI: https://doi.org/10.1097/TXD.0000000000001702

2024-08-19

Abstract:Background: Patients undergoing liver transplantation are in a state of coagulopathy before surgery because of liver failure. Intraoperative hemorrhage, massive transfusions, and post-reperfusion syndrome further contribute to coagulopathy, acidosis, and hypothermia. In such situations, temporary cessation of surgery with open abdominal management and resuscitation in the intensive care unit (ICU), which is commonly used as a damage control strategy in trauma care, may be effective. We assessed the outcomes of open abdominal management in liver transplantation and the corresponding complication rates. Methods: We retrospectively reviewed the outcomes of patients undergoing open abdominal management among 250 consecutive liver transplantation cases performed at our institution from 2009 to 2022. Results: Open abdominal management was indicated in 16 patients. The open abdomen management group had higher Model for End-stage Liver Disease scores (24 versus 16, P < 0.01), a higher incidence of previous upper abdominal surgery (50% versus 18%, P < 0.01), more pretransplant ICU treatment (31% versus 10%, P = 0.03), and more renal replacement therapy (38% versus 12%, P = 0.01). At the time of the damage control decision, coagulopathy (81%), acidosis (38%), hypothermia (31%), and a high-dose noradrenaline requirement (75%) were observed. The abdominal wall was closed in the second operation in 75% of patients, in the third operation in 19%, and in the fourth operation in 6%. Postoperatively, the frequency of early allograft dysfunction was predominantly higher in the open abdominal management group (69%), whereas the frequency of vascular complications and intra-abdominal infection was the same as in other patients. Conclusions: Open abdominal management can be a crucial option in cases of complex liver transplant complicated by conditions such as hypothermia, acidosis, coagulopathy, and hemodynamic instability. Damage control management minimizes deterioration of the patient's condition during surgery, allowing completion of the planned procedure after stabilizing the patient's overall condition in the ICU.
Infections in Kidney and Pancreas Transplantation

Megan K. Morales,Matthew Cooper,Peter Abrams,Joseph G. Timpone

DOI: https://doi.org/10.1007/978-1-4939-9034-4_4

2019-01-01

Abstract:The optimal treatment for patients with chronic kidney disease (CKD) requiring renal replacement therapy/dialysis is kidney transplantation. Additionally, pancreas transplantation alone or simultaneous pancreas-kidney transplantation offers improved quality of life as well as reversion or prevention of complications seen in patients with type 1 diabetes mellitus. Patients with CKD on dialysis are at increased risk for bacterial and blood-borne viral pathogens. During the initial first month posttransplantation period, kidney and kidney-pancreas transplant recipients are at increased risk for healthcare-acquired infections and complications associated with surgery. Over the next 6 months, during the period of maximal immunosuppression, these patients are at increased risk for opportunistic infections such as BK polyomavirus and cytomegalovirus. Anti-infective prophylactic strategies have been developed to decrease rates of specific opportunistic infections during this time period. Beyond 6 months, patients are at increased risk for community-acquired infections, including bacterial and fungal infections such as invasive molds, endemic mycoses, as well as the complications of chronic immunosuppressive therapy. This chapter provides a brief overview of kidney and pancreas transplantation with regard to types of transplantations, selection criteria, surgical procedures, and immunosuppressive regimens. It will then focus on infectious complications encountered in patients on dialysis and the pretransplantation evaluation for patients awaiting organs. Infectious complications that are specific to kidney and pancreas transplantation are reviewed in detail, including the role of anti-infective prophylaxis. Specific infectious etiologies and syndromes that are related to kidney and pancreas transplantation will also be presented.
Abdominal Gynecologic Procedures in Pancreas Transplant Recipients

Allison Drury,Sarah Huber,Elena Loya,John A. Powelson,Andrew Lutz,Kelly Kasper,Jeffrey M. Rothenberg,Jonathan A. Fridell

DOI: https://doi.org/10.1111/ctr.70004

2024-10-22

Clinical Transplantation

Abstract:Introduction With the growing population of pancreas transplant recipients followed long‐term, some female recipients are going to require surgical intervention for gynecologic symptoms and pathologies. Currently, there is a lack of literature describing how to approach this population and whether pelvic gynecologic procedures (GYN) can be performed safely given the proximity of the pancreatic (and possibly renal) allograft. In this single‐center retrospective analysis, all pancreas transplant recipients that subsequently underwent GYN were reviewed. Methods Subjects were identified by cross‐referencing all pancreas transplants performed between January 2003 and December 2022 for any subsequent GYN. Demographics at transplant and GYN, indications and procedure performed, operative time, presence and involvement of a transplant surgeon, complications length of stay, and readmissions were reviewed. Results Seventeen patients who underwent a total of 19 GYN after pancreas transplantation were identified. Operations performed included tubal ligation (n = 2), total abdominal hysterectomy with (n = 6) or without bilateral salpingectomy (n = 2), oophorectomy versus cyst drainage (n = 2), bilateral oophorectomy (n = 1), and unilateral (n = 4) versus bilateral (n = 2) salpingectomy. Four were performed through an open laparotomy and 15 were performed laparoscopically. In 11 cases, a transplant surgeon was involved intra‐operatively. Eight of the 17 patients developed post‐operative complications including post‐operative fevers, fluid overload, neutropenia, elevated creatinine (n = 2), nephrolithiasis, urinary tract infection, and incisional hernia. Five required readmission. Conclusion GYN can be performed safely following pancreas transplantation, but careful planning and the involvement of the transplant surgery team are advised.

surgery,transplantation
Postoperative Care and Outcomes in Solid Organ Transplant Patients undergoing Lower Extremity Fracture Treatment

Daniel Chiou,Bailey H Mooney,Brendan Shi,Alexander Upfill-Brown,Jennifer Kallini,Nelson SooHoo,Eric E Johnson,Bailey H. Mooney,Eric E. Johnson

DOI: https://doi.org/10.1097/bot.0000000000002788

2024-02-15

Journal of Orthopaedic Trauma

Abstract:OBJECTIVE: Determine the postoperative outcomes in solid-organ transplant (SOT) patients undergoing operative treatment of lower extremity fractures. METHODS: Design : Retrospective comparative study Setting: Academic Level 1 Trauma center Patient Selection Criteria: Patients who underwent SOT and operative treatment for lower extremity fracture from 2013-2021 were identified, excluding pathologic fractures. Outcome Measures and Comparisons : postoperative complications, length of stay, time to death, 90-day and 1-year readmission rates, readmission causes, discharge location, and immunosuppressive regiments. RESULTS: 61 patients with an average age of 67 (range 29-88) were included. The mortality rate was 37.7%. The average follow-up was 15.2 months (range of 2 weeks to 10 years). The majority of patients (42.6%) had received a liver transplant, and femoral neck fractures constituted the largest fracture group (39.4%). The average length of stay was 10 days, with the shortest being one day and the longest being 126 days (SD 18). The majority of patients were not discharged home (56.6%). Only two suffered from a postoperative complication requiring another procedure: hardware removal and liner exchange for periprosthetic joint infection, respectively. There was a 27.9% 90-day readmission rate with two deaths within that period with the most common being altered mental status (29.4%), genitourinary infections (17.6%), repeat falls (11.8%), and low hemoglobin requiring transfusion (11.8%). The longest average time to death analyzed by transplant type was found among lung transplant patients (1076 days, 62.5% mortality), followed by liver transplant patients (949 days 35.0% mortality), then kidney transplant patients (834 days, 38.9% mortality). The shortest time to death was 71 days from index procedure. CONCLUSIONS: Family members of solid-organ transplant patients undergoing operative treatment of lower extremity fractures should be made aware of the high risk for 90-day readmission postoperatively (27.9%) and overall mortality (12.5%). Providers should be aware of the need for multidisciplinary involvement for inpatient care, monitoring postoperative complications and facilitating discharge planning. LEVEL OF EVIDENCE: Level IV. See Instructions for Authors for a complete description of levels of evidence.

orthopedics,sport sciences
Successful percutaneous implantation of an aortic valve stent prosthesis in a patient with a mechanical mitral valve.

J. Schumm,M. Ferrari,H. Figulla

2011-03-01

Abstract:Percutaneous aortic valve replacement represents a minimally invasive alternative to open heart valve replacement in high-risk patients. Interventional procedures are used in an increasing number of patients and indications are broadened as techniques further evolve. However, there are still many postulated contraindications for interventional aortic valve replacement. We report a case of successful transfemoral aortic valve replacement in a patient with a mechanical mitral valve, performed due to the patient's refusal to accept blood transfusions. The feasibility and good procedural result may further extend future indications for interventional valve replacement.
Abdominal Organ Transplantation: Noteworthy Literature in 2022

Lyle Nolasco,Divya Igwe,Natalie K Smith,Tetsuro Sakai

DOI: https://doi.org/10.1177/10892532231169075

Abstract:This review highlights noteworthy literature published in 2022 pertinent to anesthesiologists and critical care physicians caring for patients undergoing abdominal organ transplantation. We begin by exploring the impacts that the COVID-19 pandemic has had across the field of abdominal organ transplantation, including the successful use of grafts procured from COVID-19-infected donors. In pancreatic transplantation, we highlight several studies on dexmedetomidine and ischemia-reperfusion injury, equity in transplantation, and medical management, as well as studies comparing pancreatic transplantation to islet cell transplantation. In our section on intestinal transplantation, we explore donor selection. Kidney transplantation topics include cardiovascular risk management, obesity, and intraoperative management, including fluid resuscitation, dexmedetomidine, and sugammadex. The liver transplantation section focuses on clinical trials, systematic reviews, and meta-analyses published in 2022 and covers a wide range of topics, including machine perfusion, cardiovascular issues, renal issues, and coagulation/transfusion.
Association of transplant recipient status with clinical and financial outcomes among patients undergoing major surgery

Muhammad Muntazir Mehdi Khan,Selamawit Woldesenbet,Muhammad Musaab Munir,Mujtaba Khalil,Yutaka Endo,Erryk Katayama,Abdullah Altaf,Zayed Rashid,Austin Schenk,Timothy M. Pawlik

DOI: https://doi.org/10.1016/j.surg.2024.06.086

IF: 4.348

2024-11-30

Surgery

Abstract:Background Transplant recipients undergoing surgery may represent a vulnerable population because of transplant-related comorbidities as well as reliance on immunosuppressive medications. We sought to characterize the association of prior transplant status on postoperative outcomes among patients undergoing major non–transplant-related surgical procedures. Methods Data on patients who underwent a major surgical procedure (pneumonectomy, coronary artery bypass graft, abdominal aortic aneurysm repair, Whipple, colectomy) between 2016 and 2020 were obtained from the Nationwide Readmission Database. After balancing the 2 cohorts using entropy balancing, multivariable regression models were used to assess the relationship between post-transplant status and patient outcomes. Results Among 1,818,973 patients, 0.45% ( n = 8,212) had a history of solid organ transplantation (liver: n = 1,773, 21.6%; heart/lung: n = 1,087, 13.2%; kidney/pancreas: n = 4,891, 59.6%; and multiple: n = 461, 5.6%). In the unmatched cohort, patients who had a history of organ transplant were more likely to be male (64.1% vs 57.7%) and have Medicare insurance (71.7% vs 59.3%) (both P < .001). On multivariable analysis, prior transplant recipient status was associated with higher odds of postoperative complications (odds ratio 1.30, 95% confidence interval 1.22–1.38), 30-day readmission (odds ratio 1.42, 95% confidence interval 1.31–1.54), and in-hospital mortality (odds ratio 1.20, 95% confidence interval 1.03–1.40) (all P < .05). Moreover, organ transplantation was associated with higher index hospitalization costs (14.4% difference, 95% confidence interval 14.1%–14.6%) and 30-day postdischarge costs (16.2% difference, 95% confidence interval 15.3%–17.0%) (both P < .001). Conclusions Prior transplant recipient status was associated with adverse clinical and financial outcomes following subsequent major surgery. Prior history of transplant may be an important factor to incorporate into risk stratification of patients undergoing subsequent major surgical procedures.

surgery
Subsyllabic structure reflected in letter confusability effects in Korean word recognition

C. Lee,M. Taft

DOI: https://doi.org/10.3758/s13423-010-0028-y

2011-02-01

Psychonomic Bulletin & Review

Abstract:
Critical care issues following orthotopic liver transplantation

M T Keegan,B W Pickering

Abstract:Orthotopic liver transplantation (OLT) remains a formidable undertaking. A multidisciplinary approach to pre-operative optimization and intra- and postoperative care of patients undergoing OLT increases the chance of a successful outcome. Although there have been moves towards avoidance of Intensive Care Unit (ICU) admission for "routine" OLT recipients, critical care practitioners continue to play a key role in liver transplant programs in the MELD era. Use of protocolized care delivery and innovative ICU therapeutic interventions have streamlined the pre-operative optimization and perioperative care of OLT recipients. The postoperative course is significantly influenced by the patient's pre-operative status, the intraoperative course and the function of the liver graft. In addition to discussion of general ICU concepts such as the use of prognostic scoring systems and protocolization of care, this review will use an organ-system based approach to describe the postoperative ICU care of OLT recipients. We discuss hemodynamic management, ventilator weaning, optimization of sedation and analgesia, and the investigation and management of renal and metabolic abnormalities. In addition, we examine postoperative complications including hemorrhage, central nervous system pathology and graft dysfunction. The review concludes with a discussion of the additional challenges practitioners face when dealing with living donor liver transplantation and donation after cardiac death.
Transient global amnesia and a father's worst nightmare.

M. Marinella

DOI: https://doi.org/10.1056/NEJM200402193500821

IF: 158.5

2004-02-19

New England Journal of Medicine

Abstract:To the Editor: Severe emotional stress can lead to a myriad of somatic or neurologic problems, including transient global amnesia, a syndrome of retrograde and anterograde memory loss without focal neurologic disturbances.1 I report the case of a healthy man who presented with transient, profound anterograde and retrograde amnesia that was precipitated by a disturbing dream. A healthy 61-year-old man was brought to the emergency department by his wife after she noticed that he was forgetful of the previous evening's activities and was unable to form new memories during the subsequent day. The patient repeated the same questions and could . . .

[The frequency of developmental abnormalities according to autopsy findings in Kecskemet and Debrecen regional hospitals].

Treatment Experience of Severe Abdominal Infection after Orthotopic Liver Transplantation

Cardiovascular and renal complications in patients receiving a solid-organ transplant

Care for the organ transplant recipient on the intensive care unit

Expert Consensus on Perioperative Management of Liver Transplantation in Adults with Acute-on-chronic Liver Failure

Perioperative Management for Patients with a Solid Organ Transplant

Surgical Procedures in Five Heart Transplant Patients

Infection in Organ Transplantation

Management of kidney transplant recipients for primary care practitioners

Transplantation: current developments and future directions

Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients.

Open Abdominal Management for Damage Control in Liver Transplantation: A Single-center Experience

Infections in Kidney and Pancreas Transplantation

Abdominal Gynecologic Procedures in Pancreas Transplant Recipients

Postoperative Care and Outcomes in Solid Organ Transplant Patients undergoing Lower Extremity Fracture Treatment

Successful percutaneous implantation of an aortic valve stent prosthesis in a patient with a mechanical mitral valve.

Abdominal Organ Transplantation: Noteworthy Literature in 2022

Association of transplant recipient status with clinical and financial outcomes among patients undergoing major surgery

Subsyllabic structure reflected in letter confusability effects in Korean word recognition

Critical care issues following orthotopic liver transplantation

Transient global amnesia and a father's worst nightmare.